| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.05 |